Characteristic immune, apoptosis and inflammatory gene profiles associated with intestinal acute cellular rejection in formalin-fixed paraffin-embedded mucosal biopsies

Tadafumi Asaoka, Eddie R. Island, Panagiotis Tryphonopoulos, Gennaro Selvaggi, Jang Moon, Akin Tekin, Alexandra Amador, David M. Levi, Jennifer Garcia, Lesley J Smith, Seigo Nishida, Debbie Weppler, Andreas G. Tzakis, Phillip Ruiz

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Small bowel transplantation (SBT) is becoming a preferred treatment for patients with irreversible intestinal failure. Despite continuous improvement of immunosuppression, SBT is plagued by a high incidence of acute cellular rejection (ACR) that is frequently intractable. Therefore, there is a need for reliable detection markers and novel immunosuppressive strategies that can achieve better control of ACR. We hypothesized that particular transcriptomes provide critical regulation of the intragraft immune response. The aim of our study was to detect potential molecular biomarkers for identifying ACR in minute mucosal biopsies. We examined 30 intestinal mucosal biopsies (AR/NR; 17/13) obtained from recipients after SBT or multivisceral transplantation. We utilized TaqMan® Gene Signature Arrays (immune, inflammation and apoptosis) and investigated the expression of 280 genes. As one of our validations, we performed immunohistochemistry for selected targets. We detected 252 mRNAs in total, 92 of which were found with significantly different expression levels between the AR and NR groups. Immunohistochemistry showed significantly increased staining for IL1R2, ICAM1, GZMB, and CCL3 (P < 0.05) during ACR. For the first time, we characterize the potential molecular changes that are associated with modulation of histological appearances of intestinal ACR. These differences in transcriptome patterns can be used to identify robust biomarkers and potential novel therapeutic targets for immunosuppressive agents.

Original languageEnglish
Pages (from-to)697-707
Number of pages11
JournalTransplant International
Volume24
Issue number7
DOIs
StatePublished - Jul 1 2011

Fingerprint

Paraffin
Formaldehyde
Transplantation
Biopsy
Immunosuppressive Agents
Transcriptome
Genes
Biomarkers
Immunohistochemistry
Immunosuppression
Apoptosis
Staining and Labeling
Inflammation
Gene Expression
Messenger RNA
Pyroptosis
Incidence
Therapeutics

Keywords

  • Gene signature
  • Human
  • Molecular biomarker
  • Multivisceral transplantation
  • Small bowel transplantation

ASJC Scopus subject areas

  • Transplantation

Cite this

Characteristic immune, apoptosis and inflammatory gene profiles associated with intestinal acute cellular rejection in formalin-fixed paraffin-embedded mucosal biopsies. / Asaoka, Tadafumi; Island, Eddie R.; Tryphonopoulos, Panagiotis; Selvaggi, Gennaro; Moon, Jang; Tekin, Akin; Amador, Alexandra; Levi, David M.; Garcia, Jennifer; Smith, Lesley J; Nishida, Seigo; Weppler, Debbie; Tzakis, Andreas G.; Ruiz, Phillip.

In: Transplant International, Vol. 24, No. 7, 01.07.2011, p. 697-707.

Research output: Contribution to journalArticle

Asaoka, Tadafumi ; Island, Eddie R. ; Tryphonopoulos, Panagiotis ; Selvaggi, Gennaro ; Moon, Jang ; Tekin, Akin ; Amador, Alexandra ; Levi, David M. ; Garcia, Jennifer ; Smith, Lesley J ; Nishida, Seigo ; Weppler, Debbie ; Tzakis, Andreas G. ; Ruiz, Phillip. / Characteristic immune, apoptosis and inflammatory gene profiles associated with intestinal acute cellular rejection in formalin-fixed paraffin-embedded mucosal biopsies. In: Transplant International. 2011 ; Vol. 24, No. 7. pp. 697-707.
@article{29abd9636e1d426ea6be1862840492c9,
title = "Characteristic immune, apoptosis and inflammatory gene profiles associated with intestinal acute cellular rejection in formalin-fixed paraffin-embedded mucosal biopsies",
abstract = "Small bowel transplantation (SBT) is becoming a preferred treatment for patients with irreversible intestinal failure. Despite continuous improvement of immunosuppression, SBT is plagued by a high incidence of acute cellular rejection (ACR) that is frequently intractable. Therefore, there is a need for reliable detection markers and novel immunosuppressive strategies that can achieve better control of ACR. We hypothesized that particular transcriptomes provide critical regulation of the intragraft immune response. The aim of our study was to detect potential molecular biomarkers for identifying ACR in minute mucosal biopsies. We examined 30 intestinal mucosal biopsies (AR/NR; 17/13) obtained from recipients after SBT or multivisceral transplantation. We utilized TaqMan{\circledR} Gene Signature Arrays (immune, inflammation and apoptosis) and investigated the expression of 280 genes. As one of our validations, we performed immunohistochemistry for selected targets. We detected 252 mRNAs in total, 92 of which were found with significantly different expression levels between the AR and NR groups. Immunohistochemistry showed significantly increased staining for IL1R2, ICAM1, GZMB, and CCL3 (P < 0.05) during ACR. For the first time, we characterize the potential molecular changes that are associated with modulation of histological appearances of intestinal ACR. These differences in transcriptome patterns can be used to identify robust biomarkers and potential novel therapeutic targets for immunosuppressive agents.",
keywords = "Gene signature, Human, Molecular biomarker, Multivisceral transplantation, Small bowel transplantation",
author = "Tadafumi Asaoka and Island, {Eddie R.} and Panagiotis Tryphonopoulos and Gennaro Selvaggi and Jang Moon and Akin Tekin and Alexandra Amador and Levi, {David M.} and Jennifer Garcia and Smith, {Lesley J} and Seigo Nishida and Debbie Weppler and Tzakis, {Andreas G.} and Phillip Ruiz",
year = "2011",
month = "7",
day = "1",
doi = "10.1111/j.1432-2277.2011.01259.x",
language = "English",
volume = "24",
pages = "697--707",
journal = "Transplant International",
issn = "0934-0874",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Characteristic immune, apoptosis and inflammatory gene profiles associated with intestinal acute cellular rejection in formalin-fixed paraffin-embedded mucosal biopsies

AU - Asaoka, Tadafumi

AU - Island, Eddie R.

AU - Tryphonopoulos, Panagiotis

AU - Selvaggi, Gennaro

AU - Moon, Jang

AU - Tekin, Akin

AU - Amador, Alexandra

AU - Levi, David M.

AU - Garcia, Jennifer

AU - Smith, Lesley J

AU - Nishida, Seigo

AU - Weppler, Debbie

AU - Tzakis, Andreas G.

AU - Ruiz, Phillip

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Small bowel transplantation (SBT) is becoming a preferred treatment for patients with irreversible intestinal failure. Despite continuous improvement of immunosuppression, SBT is plagued by a high incidence of acute cellular rejection (ACR) that is frequently intractable. Therefore, there is a need for reliable detection markers and novel immunosuppressive strategies that can achieve better control of ACR. We hypothesized that particular transcriptomes provide critical regulation of the intragraft immune response. The aim of our study was to detect potential molecular biomarkers for identifying ACR in minute mucosal biopsies. We examined 30 intestinal mucosal biopsies (AR/NR; 17/13) obtained from recipients after SBT or multivisceral transplantation. We utilized TaqMan® Gene Signature Arrays (immune, inflammation and apoptosis) and investigated the expression of 280 genes. As one of our validations, we performed immunohistochemistry for selected targets. We detected 252 mRNAs in total, 92 of which were found with significantly different expression levels between the AR and NR groups. Immunohistochemistry showed significantly increased staining for IL1R2, ICAM1, GZMB, and CCL3 (P < 0.05) during ACR. For the first time, we characterize the potential molecular changes that are associated with modulation of histological appearances of intestinal ACR. These differences in transcriptome patterns can be used to identify robust biomarkers and potential novel therapeutic targets for immunosuppressive agents.

AB - Small bowel transplantation (SBT) is becoming a preferred treatment for patients with irreversible intestinal failure. Despite continuous improvement of immunosuppression, SBT is plagued by a high incidence of acute cellular rejection (ACR) that is frequently intractable. Therefore, there is a need for reliable detection markers and novel immunosuppressive strategies that can achieve better control of ACR. We hypothesized that particular transcriptomes provide critical regulation of the intragraft immune response. The aim of our study was to detect potential molecular biomarkers for identifying ACR in minute mucosal biopsies. We examined 30 intestinal mucosal biopsies (AR/NR; 17/13) obtained from recipients after SBT or multivisceral transplantation. We utilized TaqMan® Gene Signature Arrays (immune, inflammation and apoptosis) and investigated the expression of 280 genes. As one of our validations, we performed immunohistochemistry for selected targets. We detected 252 mRNAs in total, 92 of which were found with significantly different expression levels between the AR and NR groups. Immunohistochemistry showed significantly increased staining for IL1R2, ICAM1, GZMB, and CCL3 (P < 0.05) during ACR. For the first time, we characterize the potential molecular changes that are associated with modulation of histological appearances of intestinal ACR. These differences in transcriptome patterns can be used to identify robust biomarkers and potential novel therapeutic targets for immunosuppressive agents.

KW - Gene signature

KW - Human

KW - Molecular biomarker

KW - Multivisceral transplantation

KW - Small bowel transplantation

UR - http://www.scopus.com/inward/record.url?scp=79959846503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959846503&partnerID=8YFLogxK

U2 - 10.1111/j.1432-2277.2011.01259.x

DO - 10.1111/j.1432-2277.2011.01259.x

M3 - Article

VL - 24

SP - 697

EP - 707

JO - Transplant International

JF - Transplant International

SN - 0934-0874

IS - 7

ER -